Population proteomics for equitable precision medicine.

Population proteomics is emerging as a new framework for equitable precision medicine. By studying protein variation across populations, this field bridges population genomics and conventional proteomics to capture the functional molecular states through which genetic ancestry, environmental exposures and other contextual factors shape human health. Here, we discuss how recent advances are moving population proteomics beyond biomarker discovery toward equitable clinical translation through cross-population validation, mechanistic multiomics and global research infrastructures. Its ultimate promise is not to classify populations as fixed biological categories, but to make human diversity measurable, interpretable and clinically actionable for equitable precision medicine.